Wang W, Li T, Wu K
Cell Death Discov. 2025; 11(1):93.
PMID: 40064873
PMC: 11894105.
DOI: 10.1038/s41420-025-02376-1.
Tatar M, Tufekci K, Uslu S
J Mol Histol. 2025; 56(1):74.
PMID: 39856359
DOI: 10.1007/s10735-024-10350-x.
Saxena R, Welsh C, He Y
Front Cell Dev Biol. 2024; 12:1462339.
PMID: 39620145
PMC: 11604647.
DOI: 10.3389/fcell.2024.1462339.
Chen K, Manoury-Battais S, Kanaya N, Vogiatzi I, Borges P, Kruize S
J Clin Invest. 2024; 135(2.
PMID: 39560995
PMC: 11735097.
DOI: 10.1172/JCI181143.
Gharib E, Robichaud G
Int J Mol Sci. 2024; 25(17).
PMID: 39273409
PMC: 11395697.
DOI: 10.3390/ijms25179463.
Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment.
Bykov Y, Dawodu G, Javaheri A, Garcia-Sastre A, Cuadrado-Castano S
J Cancer Metastasis Treat. 2023; 9.
PMID: 37974615
PMC: 10653360.
DOI: 10.20517/2394-4722.2022.92.
A novel necroptosis related gene signature and regulatory network for overall survival prediction in lung adenocarcinoma.
Wang G, Liu X, Liu H, Zhang X, Shao Y, Jia X
Sci Rep. 2023; 13(1):15345.
PMID: 37714937
PMC: 10504370.
DOI: 10.1038/s41598-023-41998-2.
An effective prognostic model in colon adenocarcinoma composed of cuproptosis-related epigenetic regulators.
Liu Y, Wang Y, Li C, Feng H, Liu Y, Ma L
Front Pharmacol. 2023; 14:1254918.
PMID: 37701039
PMC: 10494936.
DOI: 10.3389/fphar.2023.1254918.
RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis.
Hoff J, Xiong L, Kammann T, Neugebauer S, Micheel J, Gassler N
Cell Death Dis. 2023; 14(4):275.
PMID: 37072399
PMC: 10113265.
DOI: 10.1038/s41419-023-05794-0.
A biochemical necroptosis model explains cell-type-specific responses to cell death cues.
Ildefonso G, Metzig M, Hoffmann A, Harris L, Lopez C
Biophys J. 2023; 122(5):817-834.
PMID: 36710493
PMC: 10027451.
DOI: 10.1016/j.bpj.2023.01.035.
Mass spectroscopy-based proteomics and metabolomics analysis of triple-positive breast cancer cells treated with tamoxifen and/or trastuzumab.
Sharaf B, Giddey A, Al-Hroub H, Menon V, Okendo J, El-Awady R
Cancer Chemother Pharmacol. 2022; 90(6):467-488.
PMID: 36264351
DOI: 10.1007/s00280-022-04478-4.
Pan-cancer analysis of a novel indicator of necroptosis with its application in human cancer.
Liu A, Li Y, Shen L, Li N, Shen L, Li Z
Aging (Albany NY). 2022; 14(18):7587-7616.
PMID: 36170029
PMC: 9550240.
DOI: 10.18632/aging.204307.
Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y, Zhang R, Wang M, Li J, Dong J, He K
Front Immunol. 2022; 13:977338.
PMID: 36159818
PMC: 9504871.
DOI: 10.3389/fimmu.2022.977338.
Role of Receptor Interacting Protein (RIP) kinases in cancer.
Ermine K, Yu J, Zhang L
Genes Dis. 2022; 9(6):1579-1593.
PMID: 36157481
PMC: 9485196.
DOI: 10.1016/j.gendis.2021.10.007.
Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X, Cheng Z, Chen X, Li J
Front Genet. 2022; 13:955424.
PMID: 36046241
PMC: 9421078.
DOI: 10.3389/fgene.2022.955424.
Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K, Hong J, Chen D, Luo Z, Li J
BMC Gastroenterol. 2022; 22(1):344.
PMID: 35840882
PMC: 9284853.
DOI: 10.1186/s12876-022-02423-6.
Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
Luo W, Xiang W, Gan L, Che J, Li J, Wang Y
J Transl Med. 2022; 20(1):235.
PMID: 35590418
PMC: 9118791.
DOI: 10.1186/s12967-022-03431-6.
Necroptosis-driving genes and are associated with intratumoral CD3 and CD8 T cell density and predict prognosis in hepatocellular carcinoma.
Nicole L, Sanavia T, Cappellesso R, Maffeis V, Akiba J, Kawahara A
J Immunother Cancer. 2022; 10(3).
PMID: 35264437
PMC: 8915343.
DOI: 10.1136/jitc-2021-004031.
Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy.
Wei J, Zhao Y, Liang H, Du W, Wang L
Acta Pharm Sin B. 2022; 12(1):1-17.
PMID: 35127369
PMC: 8799881.
DOI: 10.1016/j.apsb.2021.08.026.
Platinum drugs and taxanes: can we overcome resistance?.
Sazonova E, Kopeina G, Imyanitov E, Zhivotovsky B
Cell Death Discov. 2021; 7(1):155.
PMID: 34226520
PMC: 8257727.
DOI: 10.1038/s41420-021-00554-5.